Leber, Galle & Magen-Darm
3 Minuten Lesezeit
SGLT2 inhibitors in biopsy-proven MASH patients with diabetes: Systematic review and meta-analysis (abstract interpretation)
A single-arm meta-analysis of diabetic patients with biopsy-proven MASH found SGLT2 inhibitors were associated with improvements in multiple liver, metabolic, and histologic markers versus…
